Aveanna Healthcare Holdings Inc. (AVAH) P/E Ratio History
Historical price-to-earnings valuation from 2021 to 2025
Loading P/E history...
AVAH Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Aveanna Healthcare Holdings Inc. (AVAH) trades at a price-to-earnings ratio of 6.6x, with a stock price of $6.94 and trailing twelve-month earnings per share of $1.05.
The current P/E is 93% below its 5-year average of 101.3x. Over the past five years, AVAH's P/E has ranged from a low of 7.7x to a high of 339.9x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, AVAH trades at a 70% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, AVAH trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our AVAH DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
AVAH P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $1B | 42.5 | 4.23 | +18% | |
| $2B | 18.7 | 0.93 | +23% | |
| $2B | 27.5 | - | +53%Best | |
| $10B | 29.8 | 2.16 | +14% | |
| $4B | 12.1Lowest | 1.19 | +10% | |
| $3B | 16.3 | - | +3% | |
| $4B | 20.3 | 0.41Best | +40% | |
| $336B | 27.9 | - | -15% | |
| $111B | 62.8 | - | -62% | |
| $30B | 25.1 | - | -1% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
AVAH Historical P/E Data (2021–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Sat Jan 03 2026 00:00:00 GM | $8.08 | $1.05 | 7.7x | -92% |
| FY2025 Q3 | Sat Sep 27 2025 00:00:00 GM | $8.75 | $0.36 | 24.4x | -76% |
| FY2025 Q2 | Sat Jun 28 2025 00:00:00 GM | $5.02 | $0.08 | 66.8x | -34% |
| FY2025 Q1 | Sat Mar 29 2025 00:00:00 GM | $5.37 | $0.02 | 339.9x | +235% |
| FY2021 Q2 | Sat Jul 03 2021 00:00:00 GM | $12.47 | $0.18 | 67.8x | -33% |
Average P/E for displayed period: 101.3x
See AVAH's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AVAH Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AVAH vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAVAH — Frequently Asked Questions
Quick answers to the most common questions about buying AVAH stock.
Is AVAH stock overvalued or undervalued?
AVAH trades at 6.6x P/E, below its 5-year average of 101.3x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does AVAH's valuation compare to peers?
Aveanna Healthcare Holdings Inc. P/E of 6.6x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is AVAH's PEG ratio?
AVAH PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2021-2025.